Bernhard Wörmann

发表

Implementation of a clinical long-term follow-up database for adult childhood cancer survivors in Germany: a feasibility study at two specialised late effects clinics

A. Kock-Schoppenhauer, D. Grabow, A. Neumann, 2023, Journal of Cancer Research and Clinical Oncology.

Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome

W. Hiddemann, K. Metzeler, K. Spiekermann, 2023, British journal of haematology.

Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group.

W. Hiddemann, T. Haferlach, C. Schoch, 1999, Blood.

Activity of thymidine kinase and of polymerase alpha as well as activity and gene expression of deoxycytidine deaminase in leukemic blasts are correlated with clinical response in the setting of granulocyte-macrophage colony-stimulating factor-based priming before and during TAD-9 induction therapy

W. Hiddemann, C. Reuter, T. Büchner, 1997, Blood.

Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML

W. Hiddemann, T. Haferlach, S. Schnittger, 2000, Leukemia.

Satelite Symposium V, Meet-the-Professor Sessions I and II, Main Sessions I-IX

W. Kern, H. Serve, L. Balleisen, 2004, Annals of Hematology.

High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG

W. Hiddemann, T. Haferlach, K. Spiekermann, 2009, Leukemia.

Acute Promyelocytic Leukemia (APL)

R. Schlenk, C. Bokemeyer, D. Niederwieser, 2010 .

Frequency and Clinical Significance of DNA Aneuploidy in Acute Leukemia

E. Thiel, W. Hiddemann, W. Göhde, 1986, Annals of the New York Academy of Sciences.

Differential pattern of DNA-aneuploidy in human malignancies.

W. Hiddemann, K. Müller, W. Göhde, 1985, Pathology, research and practice.

Management of acute myeloid leukemia in elderly patients.

W. Hiddemann, C. Schoch, W. Kern, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A prospective randomised phase-II trial with gemcitabine versus gemcitabine plus sunitinib in advanced pancreatic cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV.

J. Rüssel, M. Scheulen, L. Bergmann, 2015, European journal of cancer.

Low- versus high-dose radioimmunotherapy with humanized anti-CD22 or chimeric anti-CD20 antibodies in a broad spectrum of B cell-associated malignancies.

W. Hiddemann, B. Wörmann, M. Béhé, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical study.

W. Hiddemann, A. Fayyazi, B. Wörmann, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

Endotoxin concentration in neutropenic patients with suspected gram-negative sepsis: correlation with clinical outcome and determination of anti-endotoxin core antibodies during therapy with polyclonal immunoglobulin M-enriched immunoglobulins

W. Hiddemann, G. Behre, B. Wörmann, 1992, Antimicrobial Agents and Chemotherapy.

Satelite Symposium V, Meet-the-Professor Sessions I and II, Main Sessions I-IX

J. Downing, M. Relling, D. Campana, 2004, Annals of Hematology.

De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance.

W. Hiddemann, C. Schoch, J. Bennett, 1996, Leukemia.

The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia

W. Hiddemann, G. Lenz, G. Sauvageau, 2019, Leukemia.

A four-gene LincRNA expression signature predicts risk in multiple cohorts of acute myeloid leukemia patients

W. Hiddemann, S. Bohlander, A. Schwarzer, 2018, Leukemia.

MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis.

W. Hiddemann, S. Bohlander, C. Schoch, 1998, Blood.

Partial tandem duplications of the MLL gene are detectable in peripheral blood and bone marrow of nearly all healthy donors.

W. Hiddemann, S. Schnittger, B. Wörmann, 1998, Blood.

Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse

E. Hoster, W. Hiddemann, S. Bohlander, 2014, Leukemia.

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of t

N. Schmitz, W. Hiddemann, M. Boccadoro, 2005, Blood.

Somatostatin receptor scintigraphy in the staging of lymphomas.

W. Hiddemann, D. Emrich, B. Wörmann, 1997, Leukemia & lymphoma.

Treatment of advanced chronic lymphocytic leukemia by fludarabine

W. Hiddemann, T. Büchner, B. Wörmann, 1991, Annals of Hematology.

Age, not therapy intensity, determines outcomes of adults with acute myeloid leukemia

C Haferlach, W Hiddemann, T Haferlach, 2016, Leukemia.

Granulocyte-macrophage colony-stimulating factor and interleukin-3 enhance the incorporation of cytosine arabinoside into the DNA of leukemic blasts and the cytotoxic effect on clonogenic cells from patients with acute myeloid leukemia.

W. Hiddemann, T. Büchner, B. Wörmann, 1992, Seminars in Oncology.

Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117

W. Hiddemann, C. Schoch, B. Wörmann, 1997, Leukemia.

Stimulation of B-chronic lymphocytic leukemia cells by murine fibroblasts, IL-4, anti-CD40 antibodies, and the soluble CD40 ligand.

W. Hiddemann, C. Buske, B. Wörmann, 1997, Experimental hematology.

Recommendations from the society for diagnosis and therapy of haematological and oncological diseases Acute Promyelocytic Leukemia ( APL )

R. Schlenk, M. Hallek, D. Niederwieser, 2018 .

TGF-β inhibits growth and induces apoptosis in leukemic B cell precursors

W. Hiddemann, C. Buske, B. Wörmann, 1997, Leukemia.